Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Replimune Group Inc
REPLCurrent price
11.05 USD
+0.22 USD (+2.03%)
Last closed
10.82 USD
Company
www.replimune.com
ISIN
US76029N1063
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
960 408 320 USD
Yield for 12 month
+37.27 %
1Y
3Y
5Y
10Y
15Y
REPL
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts. Address: 500 Unicorn Park Drive, Woburn, MA, United States, 01801
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
16.88 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-2 655 000 USD
Last Year
-2 447 000 USD
Current Quarter
–
Last Quarter
-736 000 USD
Key Figures REPL
1 year
3 years
5 years
10 years
EBITDA
-226 706 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-27.07 %
PEG Ratio
–
Return On Equity TTM
-50.32 %
Wall Street Target Price
16.88 USD
Revenue TTM
–
Book Value
5.58 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-3.04 USD
Diluted Eps TTM
-3.04 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics REPL
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History REPL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation REPL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.24
Price Book MRQ
2.52
Financials REPL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators REPL
For 52 weeks
4.92 USD
17.00 USD
50 Day MA
12.14 USD
Shares Short Prior Month
6 684 288
200 Day MA
9.51 USD
Short Ratio
5.61
Shares Short
5 582 789
Short Percent
10.01 %
BeatStart